Bio-Techne
TECH
#1459
Rank
$12.06 B
Marketcap
$75.93
Share price
2.04%
Change (1 day)
32.98%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Bio-Techne (TECH) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : $0.59 Billion USD

According to Bio-Techne's latest financial reports the company's total liabilities are $0.59 Billion USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Bio-Techne - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-06-30$0.67 B13.2%
2022-06-30$0.59 B-14.16%
2021-06-30$0.69 B7.01%
2020-06-30$0.64 B-10.08%
2019-06-30$0.71 B39.81%
2018-06-30$0.51 B-15.52%
2017-06-30$0.60 B143.14%
2016-06-30$0.25 B15.65%
2015-06-30$0.21 B221.94%
2014-06-30$67.22 M65.76%
2013-06-30$40.55 M-9.64%
2012-06-30$44.88 M42.27%
2011-06-30$31.54 M85.31%
2010-06-30$17.02 M9.67%
2009-06-30$15.52 M-23.3%
2008-06-30$20.23 M17.72%
2007-06-30$17.19 M-43%
2006-06-30$30.16 M10.11%
2005-06-30$27.39 M-2.29%
2004-06-30$28.03 M5.16%
2003-06-30$26.66 M-15.98%
2002-06-30$31.73 M-16.2%
2001-06-30$37.86 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
$51.26 B 8,481.83%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.11 B 421.56%๐Ÿ‡บ๐Ÿ‡ธ USA
$29.71 B 4,873.99%๐Ÿ‡บ๐Ÿ‡ธ USA
$29.31 B 4,806.53%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.17 B 264.83%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
$107.59 B 17,911.54%๐Ÿ‡บ๐Ÿ‡ธ USA
$29.65 M-95.04%๐Ÿ‡บ๐Ÿ‡ธ USA